After retained placental tissue is removed from the uterus during dilation and curettage, which antibiotic should be administered for prophylaxis to prevent infection?

Antibiotic Prophylaxis After D&C for Retained Placental Tissue

Administer a single dose of ampicillin 2 g IV plus metronidazole 500 mg IV immediately after the D&C procedure for retained placental tissue removal.

Recommended Antibiotic Regimen

The evidence-based approach for antibiotic prophylaxis after uterine instrumentation for retained placental tissue is straightforward:

Primary regimen:

• Ampicillin 2 g IV + Metronidazole 500 mg IV (single dose) 1

Alternative if patient already received GBS prophylaxis:

• Metronidazole 500 mg IV alone (single dose) 1

Alternative if β-lactam allergy:

• Cefazolin 1 g IV + Metronidazole 500 mg IV (single dose) 1

Rationale and Microbiology

The combination of ampicillin and metronidazole provides comprehensive coverage against the polymicrobial flora responsible for postpartum endometritis:

• Ampicillin covers aerobic Gram-positive cocci (Streptococcus, Enterococcus) and aerobic Gram-negative bacilli (E. coli, Klebsiella, Proteus) 2
• Metronidazole provides essential anaerobic coverage (Bacteroides, Prevotella, anaerobic Gram-positive cocci) 1, 2

Uterine instrumentation introduces vaginal and cervical flora into the uterine cavity, creating risk for ascending infection. The retained placental tissue itself serves as a nidus for bacterial growth, making prophylaxis particularly important 1.

Timing Considerations

Unlike cesarean delivery where antibiotics are given before incision 3, postpartum D&C prophylaxis is administered immediately after the procedure 1. This timing difference reflects that:

1. The procedure has already been completed
2. The goal is preventing infection from introduced bacteria rather than surgical site infection
3. There is no concern about neonatal antibiotic exposure

Evidence Quality and Nuances

Important caveats:

• The evidence for D&C prophylaxis after retained placental tissue is less robust than for cesarean delivery. A 2023 review specifically addressing postpartum uterine instrumentation provides the clearest guidance 1

• A 2025 Cochrane review on miscarriage management showed that prophylactic antibiotics may reduce uterine infection by 43% when high-quality studies are analyzed, though overall evidence certainty was mixed 4

• Older studies on elective D&C for abnormal bleeding showed no benefit from antibiotics 5, but retained placental tissue represents a higher-risk scenario with devitalized tissue and recent delivery

• The 2012 Canadian guidelines state there is insufficient evidence for prophylaxis in missed or incomplete abortion 6, but retained placental tissue after delivery carries higher infection risk due to the postpartum state

Special Circumstances

If patient received intrapartum antibiotics for GBS prophylaxis:

• Ampicillin coverage is already present
• Give metronidazole 500 mg IV alone to add anaerobic coverage 1

Severe β-lactam allergy:

• Use clindamycin 900 mg IV + gentamicin 5 mg/kg IV (adapted from cesarean delivery guidelines) 3
• This provides Gram-positive, anaerobic, and Gram-negative coverage

Morbid obesity (BMI >35 kg/m²):

• Consider doubling antibiotic doses 6
• Ampicillin 4 g IV + Metronidazole 1 g IV

What NOT to Do

• Do not use cefazolin alone—it lacks adequate anaerobic coverage needed for postpartum uterine infections 1
• Do not extend prophylaxis beyond a single dose unless signs of established infection develop 1
• Do not withhold antibiotics based on negative cultures—prophylaxis prevents infection rather than treats it
• Do not use fluoroquinolones—they are unnecessary and promote resistance 7

Clinical Algorithm

1. Immediately after D&C completion → Administer antibiotics
2. Check recent antibiotic history:
   • No recent antibiotics → Ampicillin 2 g IV + Metronidazole 500 mg IV
   • Recent GBS prophylaxis → Metronidazole 500 mg IV only
   • β-lactam allergy → Clindamycin 900 mg IV + Gentamicin 5 mg/kg IV
3. Single dose only—no additional doses needed unless infection develops
4. Monitor for signs of endometritis (fever, uterine tenderness, foul discharge) over next 2-4 weeks

This straightforward approach balances infection prevention with antibiotic stewardship, using the narrowest effective spectrum for the shortest duration necessary.